Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: 
an analysis of four patients with biallelic RPE65 gene mutations

Marcin Stopa; Zuzanna Niedziela-Schwartz; Martyna Mieszczak; Piotr Rakowicz; Maciej Krawczyński

doi:10.5114/ko.2025.152089

POLSKI

eISSN: 2719-3209
ISSN: 0023-2157

Klinika Oczna / Acta Ophthalmologica Polonica

Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2025
vol. 127

Send email

Copy url:

Original article

Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: an analysis of four patients with biallelic RPE65 gene mutations

Marcin Stopa

¹

,

Zuzanna Niedziela-Schwartz

¹

,

Martyna Mieszczak

¹

,

Piotr Rakowicz

¹

,

Maciej Krawczyński

^{2, 3}

Eye Diseases Clinic, Department of Eye Diseases and Optometry, Poznan University of Medical Sciences, Poland
Department of Medical Genetics, Poznan University of Medical Sciences, Poland
Genesis Medical Genetics Center in Poznan, Poland

KLINIKA OCZNA 2025, 127, 2: 71-79

DOI: https://doi.org/10.5114/ko.2025.152089

Online publish date: 2025/06/23

Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Stopa M, Niedziela-Schwartz Z, Mieszczak M, Rakowicz P, Krawczyński M. Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: 
an analysis of four patients with biallelic RPE65 gene mutations. Klinika Oczna / Acta Ophthalmologica Polonica. 2025;127(2):71-79. doi:10.5114/ko.2025.152089.

APA

Stopa, M., Niedziela-Schwartz, Z., Mieszczak, M., Rakowicz, P.,  & Krawczyński, M. (2025). Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: 
an analysis of four patients with biallelic RPE65 gene mutations. Klinika Oczna / Acta Ophthalmologica Polonica, 127(2), 71-79. https://doi.org/10.5114/ko.2025.152089

Chicago

Stopa, Marcin, Zuzanna Niedziela-Schwartz, Martyna Mieszczak, Piotr Rakowicz,  and Maciej Krawczyński. 2025. "Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: 
an analysis of four patients with biallelic RPE65 gene mutations". Klinika Oczna / Acta Ophthalmologica Polonica 127 (2): 71-79. doi:10.5114/ko.2025.152089.

Harvard

Stopa, M., Niedziela-Schwartz, Z., Mieszczak, M., Rakowicz, P.,  and Krawczyński, M. (2025). Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: 
an analysis of four patients with biallelic RPE65 gene mutations. Klinika Oczna / Acta Ophthalmologica Polonica, 127(2), pp.71-79. https://doi.org/10.5114/ko.2025.152089

MLA

Stopa, Marcin et al. "Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: 
an analysis of four patients with biallelic RPE65 gene mutations." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 127, no. 2, 2025, pp. 71-79. doi:10.5114/ko.2025.152089.

Vancouver

Stopa M, Niedziela-Schwartz Z, Mieszczak M, Rakowicz P, Krawczyński M. Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: 
an analysis of four patients with biallelic RPE65 gene mutations. Klinika Oczna / Acta Ophthalmologica Polonica. 2025;127(2):71-79. doi:10.5114/ko.2025.152089.

PlumX metrics:

Early experiences with voretigene neparvovec (Luxturna) gene therapy in Poland: an analysis of four patients with biallelic RPE65 gene mutations

Marcin Stopa 1 , Zuzanna Niedziela-Schwartz 1 , Martyna Mieszczak 1 , Piotr Rakowicz 1 , Maciej Krawczyński 2, 3

Marcin Stopa

¹

,

Zuzanna Niedziela-Schwartz

¹

,

Martyna Mieszczak

¹

,

Piotr Rakowicz

¹

,

Maciej Krawczyński

^{2, 3}